Michel Chalhoub is a Respiratory physician affiliated with Northwell Health. OpenAlex indexes 161 publications with 1,519 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
501 Seaview Avenue
Suite 102
Staten Island, NY 10305
Telephone
718-980-5700Registry record last updated 29 Jun 2009.
Clinical trials
- The Use of Heliox in Obstructive Sleep Apnea Syndrome
Sponsor: Northwell Health
- Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction
Sponsor: Northwell Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- INTUITIVE SURGICAL, INC.Program year20241 payment
- Intuitive Surgical, Inc.Program year20235 payments
- United Therapeutics CorporationProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.1%Corticosteroid44.1%Trelegy Ellipta34%Breo Ellipta27%Arnuity Ellipta13%Breztri Aerosphere8%Fluticasone Propionate7%Symbicort6%Budesonide-Formoterol Fumarate4%Qvar Redihaler1%Part D<11 patientsbeta2-Adrenergic Agonist18.5%Albuterol Sulfate Hfa91%Ventolin Hfa9%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.8%Corticosteroid9.3%Prednisone100%Part D≥150 patientsProton pump inhibitor0.5%Lansoprazole100%Part D<11 patientsBlood & clotting
2.8%Factor Xa inhibitor2.8%Eliquis100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The calcium-clot connection: investigating the association between primary hyperparathyroidism and acute venous thromboembolism
Journal of Thrombosis and Thrombolysis
2023 - The Role and Efficacy of Vitamin C in Sepsis: A Systematic Review and Meta-Analysis
Advances in respiratory medicine
2022 - Bilateral pneumothorax as possible atypical presentation of coronavirus disease 2019 (COVID-19)
Respiratory Medicine Case Reports
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Gregersen
Northwell Health
Louis Kavoussi, MD
Northwell Health
David Eidelberg, MD
Northwell Health
Francisco Esteva, MD, PhD
Northwell Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”